Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors

Journal of Medicinal Chemistry

Volumn 52, Issue 23, 2009, Pages 7887-7891

  Dang, Zhao ^a   Lai, Weihong ^a   Qian, Keduo ^b   Ho, Phong ^a   Lee, Kuo Hsiung ^b   Chen, Chin Ho ^a   Huang, Li ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (8 BETULINOYLAMINOOCTANOYLAMINO) 3 HYDROXY 6 METHYLHEPTANOIC ACID; A 43D; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BETULIC ACID; BETULIC ACID DERIVATIVE; BEVIRIMAT; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; IC 50; NONHUMAN; VIRUS INHIBITION; VIRUS STRAIN;

ANTI-HIV AGENTS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HIV-1; HIV-2; HUMANS; INHIBITORY CONCENTRATION 50; TRITERPENES;

EID: 72249105530     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9004253     Document Type: Article

References (21)

1. Jaffar, S.; Grant, A. D.; Whitworth, J.; Smith, P. G.; Whittle, H. The natural history of HIV-1 and HIV-2 infections in adults in Africa: a literature review. Bull. W. H. O. 2004, 82, 462-469.
2. da Silva; Oliveira, I.; Andersen, A.; Dias, F.; Rodrigues, A.; Holmgren, B.; Andersson, S.; Aaby, P. Changes in prevalence and incidence of HIV-1, HIV-2 and dual infections in urban areas of Bissau, Guinea-Bissau: Is HIV-2 disappearing?. AIDS 2008, 19, 1195-1202.
3. Wainberg, M. A.; Jeang, K. T. 25 years of HIV-1 research. Progress and perspectives. BMC Med. 2008, 6, 31.
4. Witvrouw, M.; Pannecouque, C.; Van Laethem, K.; Desmyter, J.; De Clercq, E.; Vandamme, A. M. Activity of non-nucleoside reverse transcriptase inhibitors against HIV-2 and SIV. AIDS 1999, 13, 1477-1483. (Pubitemid 29396678)
5. Isaka, Y.; Miki, S.; Kawauchi, S.; Suyama, A.; Sugimoto, H.; Adachi,A.;Miura, T.;Hayami, M.;Yoshie, O.;Fujiwara, T.; Sato,A. A single amino acid change at Leu-188 in the reverse transcriptase of HIV-2 and SIV renders them sensitive to non-nucleoside reverse transcriptase inhibitors. Arch. Virol. 2001, 146, 743-755.
6. Witvrouw, M.; Pannecouque, C.; Switzer, W. M.; Folks, T. M.; De Clercq, E.; Heneine, W. Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis. Antiviral Ther. 2004, 9, 57-65.
7. Guyader, M.; Emerman, M.; Sonigo, P.; Clavel, F.; Montagnier, L.; Alizon, M. Genome organization and transactivation of the human immunodeficiency virus type 2. Nature 1987, 326, 662-669. (Pubitemid 17059786)
8. Kashiwada,Y; Hashimoto, F.; Cosentino, L. M.; Chen, C. H.; Lee, K. H. Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agent. J. Med. Chem. 1996, 39, 1016-1017.
9. Huang, L.; Yuan, X.; Aiken, C.; Chen, C. H. Bifunctional anti-HIV-1 small molecules with two novel mechanisms of action. Antimicrob. Agents Chemother. 2004, 48, 663-665.
10. Huang, L.; Ho, P.; Lee, K. H.; Chen, C. H. Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives. Bioorg. Med. Chem. 2006, 14, 2279-2289.
11. Huang, L.; Chen, C. H. The molecular targets of anti-HIV-1 triterpenes. Curr. Drug Targets: Infect. Disord. 2002, 2, 33-36.
12. Soler, F.; Poujade, C.; Evers, M.; Carry, J. C.;Hénin, Y.; Bousseau, A.; Huet, T.; Pauwels, R.; De Clercq, E.; Mayaux, J. F.; Le Pecq, J. B.; Dereu, N. Betulinic acid derivatives: a new class of specific inhibitors of human immunodeficiency virus type 1 entry. J. Med. Chem. 1996, 39, 1069-1083.
13. Hashimoto, F.; Kashiwada, Y.; Cosentino, L. M.; Chen, C. H.; Garrett, P. E.; Lee, K. H. Anti-AIDS agent - XXVII. Synthesis and anti-HIV activity of betulinic acid and dihydrobetulinic acid derivatives. Bioorg. Med. Chem. 1997, 5, 2133-2143.
14. Yu, D.; Sakurai, Y.; Chen, C. H.; Chang, F. R.; Huang, L.; Kashiwada, Y.; Lee, K. H. Anti-AIDS agents. 69. Moronic acid and other triterpene derivatives as novel potent anti-HIV agents. J. Med. Chem. 2006, 49, 5462-5469.
15. Huang, L.; Yu, D.; Ho, P.; Lee, K. H.; Chen, C.-H. Synthesis and anti-HIV activity of bi-functional triterpene derivatives. Lett. Drug Des. Discovery 2007, 4, 471-478.
16. Huang, L.; Lai, W. H.; Ho, P.; Chen, C. H. Induction of a nonproductive conformational change in gp120 by a small molecule HIV-1 entry inhibitor. AIDS Res. Hum. Retroviruses 2007, 23, 28-32.
17. Lai, W.; Huang, L.; Ho, P.; Li, Z. J.; Montefiori, D.; Chen, C. H. Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of HIV-1. Antimicrob. Agents Chemother. 2008, 52, 128-136.
18. Zhou, J.; Chen, C. H.; Aiken, C. The sequence of the CA-SP1 junction accounts for the differential sensitivity of HIV-1 and SIV to the small molecule maturation inhibitor 3-O-{30,30-dimethylsuccinyl} betulinic acid. Retrovirology 2004, 1-15.
19. Li, F.; Zoumplis, D.; Matallana, C.; Kilgore, N. R.; Reddick, M.; Yunus, A. S.; Adamson, C. S.; Salzwedel, K.; Martin, D. E.; Allaway, G. P.; Freed, E. O.; Wild, C. T. Determinants of activity of the HIV-1 maturation inhibitor PA-457. Virology 2006, 356, 217-224.
20. Martin, D. E.; Salzwedel, K.; Allaway, G. P. Bevirimat: a novel maturation inhibitor for the treatment of HIV-1 infection. Antiviral Chem. Chemother. 2008, 19, 107-113.
21. Davis, K. L.; Bibollet-Ruche, F.; Li, H.; Decker, J. M.; Kutsch, O.; Morris, L.; Salomon, A.; Pinter, A.; Hoxie, J. A.; Hahn, B. H.; Kwong, P. D.; Shaw, G. M. Human immunodeficiency virus type 2 (HIV-2)/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasma. J. Virol. 2009, 83, 1240-1259.